Evaluating chemiluminescent immunoassays for syphilis detection: A comparative analysis

View/ Open
Publisher version (Check access options)
Check access options
Date
2025-06-30Author
Ahmed, IsmailYounes, Nadin
Ayoub, Houssein
Nasrallah, Dana F.
Al-Emadi, Jawaher A.
Khalid, Hadiya M.
Abouassali, Mazen Najib
Elshaikh, Manal
Karimeh, Ibrahim Wissam
Ibrahim, Mohammed Abdelfatah
Ali, Mutaz Mohamed
Shaar, Ibrahim Al
Younes, Salma
Zein, Nouran
Nizamuddin, Parveen Banu
Yassine, Hadi M.
Abu-Raddad, Laith J.
Nasrallah, Gheyath K.
...show more authors ...show less authors
Metadata
Show full item recordAbstract
BackgroundSyphilis, caused by Treponema pallidum (TP), remains a significant global public health concern, with approximately 8 million new cases annually. Diagnosing syphilis is challenging due to its often-asymptomatic nature during latent stages, necessitating a combination of diagnostic methods. This study evaluates the performance of a novel chemiluminescent immunoassay (CLIA) developed by Mindray for detecting TP antibodies, comparing it to the widely used Abbott ARCHITECT Syphilis Treponemal Test (Architect-TP), the rapid plasma regain (RPR) test, and the Fujiribio INNO-LIA® Syphilis Score line immunoassay (INNO-LIA-TP). MethodsWe selected 180 samples that exhibited agreement or discrepancies between the RPR and Architect-TP assays. The selection included 40 cases that were RPR positive and Architect-TP positive, 40 cases that were RPR positive and Architect-TP negative, and 100 cases that were negative in both RPR and Architect-TP. All samples underwent re-testing using the Mindray-TP and INNO-LIA-TP assays. ResultsMindray-TP and Architect-TP exhibited excellent sensitivity of 100 % (95 % CI: 91–100) and specificity of 100 % (95 % CI: 97.4–100), with perfect agreement (κ= 1.00) compared to INNO-LIA-TP. Notably, 40 cases (28.6 %; 40/140) demonstrated false-positive results when using the RPR test compared to INNO-LIA-TP, indicating a substantial false-positive rate for the RPR assay. ConclusionThis study highlights the high diagnostic accuracy of the Mindray-TP assay, positioning it as a reliable and efficient tool for syphilis screening in high-volume laboratories. Given its operational efficiency and strong agreement with gold-standard assays, Mindray-TP can enhance diagnostic workflows, leading to timely syphilis detection and improved patient outcomes.
Collections
- Biomedical Research Center Research [764 items ]
- Biomedical Sciences [763 items ]
- Mathematics, Statistics & Physics [781 items ]